In the healthcare sector, companies often work towards crucial events or milestones that can drive significant changes in a ...

Aucatzyl is the first CAR-T cell therapy approved by the FDA with no requirement for a risk evaluation mitigation strategy ...

The expression of MICA/B cell-surface proteins is induced by cellular stress ... or other attributes to warrant further ...

A central question in adult stem cell biology is elucidating the signaling pathways regulating their dynamics and function in diverse physiological and age-related contexts. Muscle stem cells in ...

Nkarta is set to report data from its CAR-NK cell therapy, NKX019 ... who may not be licensed or certified by any institute or regulatory body.

The histone acetyltransferase KAT2A, and its paralog KAT2B have been identified as key drivers of tumor cell plasticity in small-cell lung cancer (SCLC). Researchers from Auron Therapeutics Inc. aimed ...

To avoid losing over $20 billion in cocoa exports within three years, stakeholders are taking proactive measures ahead of the European Union To avoid losing over $20 billion in cocoa exports ...

B.C. wineries are celebrating vine survival despite harsh winter, thanks in part to regulatory changes from the government.Wine BC Government help snipping red tape and resilient grape vines in ...

Most notably, QuantumScape revealed it has started the production of low volumes of its first B-sample cells, which are now being shipped for testing by automotive customers. Achieving this ...

Be Biopharma Inc. has developed a CRISPR/Cas9-based precision B-cell gene therapy to deliver active tissue non-specific alkaline phosphatase (ALP) for the potential treatment of hypophosphatasia (HPP) ...

According to the company, it has begun low-volume production of its initial B-sample cells, which will soon be sent to automotive partners for EV implementation testing. The decade-plus journey ...